Feedback / Questions
Zinapar (darinaparsin) - Solasia, Meiji Seika
https://www.businesswire.com/news/home/20210630005395/en/%C2%A0Solasia-Announces-Submission-of-New-Drug-Application-for-Anti-cancer-Drug-DARINAPARSIN-for-Peripheral-T-Cell-Lymphoma-in-Japan
Jun 30, 2021
SHARE THIS
Print
Email
More sharing
Reddit
StumbleUpon
Delicious
Prev
Next